Canaccord Genuity Lowers CannTrust (TSE:TRST) to Hold

Canaccord Genuity lowered shares of CannTrust (TSE:TRST) from a speculative buy rating to a hold rating in a report published on Thursday, BayStreet.CA reports. The firm currently has C$5.00 price objective on the stock, down from their prior price objective of C$12.00.

A number of other research firms have also commented on TRST. Cormark increased their price target on Parex Resources from C$32.50 to C$35.00 in a research report on Tuesday, July 9th. Eight Capital decreased their price target on CannTrust from C$25.00 to C$17.00 in a research report on Friday, March 29th. Bank of America restated a buy rating and set a C$11.00 price target on shares of CannTrust in a research report on Friday, May 24th. Finally, Jefferies Financial Group increased their price target on Monster Beverage from $65.00 to $70.00 and gave the stock a buy rating in a research report on Friday, May 3rd.

TSE TRST opened at C$3.34 on Thursday. The company has a market cap of $667.80 million and a price-to-earnings ratio of -27.60. CannTrust has a one year low of C$3.26 and a one year high of C$15.50. The stock’s 50 day simple moving average is C$6.65. The company has a debt-to-equity ratio of 8.20, a quick ratio of 1.90 and a current ratio of 5.64.

About CannTrust

CannTrust Holdings Inc produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc was incorporated in 2015 and is headquartered in Vaughan, Canada.

See Also: Differences Between Momentum Investing and Long Term Investing

Receive News & Ratings for CannTrust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust and related companies with MarketBeat.com's FREE daily email newsletter.